Deep learning-based radiomics does not improve residual cancer burden prediction post-chemotherapy in LIMA breast MRI trial - Quiz - MDSpire

Deep learning-based radiomics does not improve residual cancer burden prediction post-chemotherapy in LIMA breast MRI trial

  • By

  • Markus H. A. Janse

  • Liselore M. Janssen

  • Elian J. M. Wolters-van der Ben

  • Maaike R. Moman

  • Max A. Viergever

  • Paul J. van Diest

  • Kenneth G. A. Gilhuijs

  • August 6, 2025

  • 0 min

Share

Original Source(s)

Deep learning-based radiomics does not improve residual cancer burden prediction post-chemotherapy in LIMA breast MRI trial

  • by Markus H. A. Janse, Liselore M. Janssen, Elian J. M. Wolters-van der Ben, Maaike R. Moman, Max A. Viergever, Paul J. van Diest, Kenneth G. A. Gilhuijs

  • August 6, 2025

Related Content

How to practice breast self-awareness

AI-mediated ultrasound radiomics in the diagnosis and treatment of triple-negative breast cancer: research progress and future challenges

Enhanced Prediction of HER2 Status in Breast Cancer through the Integration of Intratumoral and Peritumoral Radiomic Features from DCE-MRI